연구

연구업적

최근 5년 연구업적 현황
연도 2025년 2024년 2023년 2022년 2021년
SCI 논문
발표편수
책임 196편 179편 173편 163편 184편
공동 132편 147편 120편 115편 136편
합계 328편 326편 293편 278편 320편
3665. Trained immunity induced by DAMPs and LAMPs in chronic inflammatory diseases
Hee Young Kim # 1 2, Won-Woo Lee # 3 4 5 6
Exp Mol Med. 2025 Oct;57(10):2137-2147. Link
3664. Feasibility and initial clinical application of a digital health-enabled 3D VR education model to improve health literacy in thyroid surgery
Jong-Hyuk Ahn, Soon Ho Yoon, Jong-Min Kim, Sulgina Kim, Young Hoon Jeong, Hyeonuk Hwang, Sang Joon Park, Su-Jin Kim, Kyu Eun Lee
Digit Health. 2025 Nov 6:11:20552076251394962 Link
3663. Phase II study evaluating the safety and efficacy of neratinib and trastuzumab biosimilar in patients with HER2 mutated advanced solid tumors: KCSG AL20-17/KM23 trial.
Lee K, Lee KH, Kim DW, Yoon J, Choi YJ, Lee S, Kim JW, Park KH, Choi W, Lee Y, Ryu H, Koo DH, Lee Y, Jeung HC, Lee MY, Lee N, Kang MJ, Lee J, Hong SH, Kang EJ, Park IH.
Cancer Commun (Lond). 2025 Jul;45(7):841-845 Link
3662. Elimusertib, a Novel ATR Inhibitor, Induces Anti-Tumor Effects through Replication Catastrophe in Breast Cancers
Kim M, Min A, Kim S, Kim S, Kim YJ, Ham S, Lee M, Lee EY, Kim J, Lee DW, Lee KH, Im SA.
Cancer research and treatment [Epub ahead of print] Link
3661. Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers.
Woo S, Park PG, An T, Fatima M, Moon YE, Lee SY, Youn H, Hong KJ.
Hum Vaccin Immunother. 2025 Dec;21(1):2457187 Link
3660. Promising Vaccine Formulations for Emerging Infectious Diseases.
Park PG, Lee SY, Youn H, Hong KJ.
Int J Mol Sci. 2025 May 20;26(10):4893. Link
3659. Preferential Sensitivity of the EGFR L858M/L861R Mutation to Second-Generation EGFR Tyrosine Kinase Inhibitors in Non-small Cell Lung Cancer.
Lee C, Kim S, Kim S, Park T, Kim M, Keam B, Kim TM, Kim DW, Youk J.
Cancer Res Treat. 2025 Aug 20. doi: 10.4143/crt.2025.279. Online ahead of print. Link
3658. Deciphering Breast Origin in Malignant Effusions: The Diagnostic Utility of an MGP, GATA-3, and TRPS-1 Immunocytochemical Panel
So Hyeon Yang 1 2, Jae Seok Lee 3, Ji Won Koh 1 2, Ilias P Nikas 4, Eun Na Kim 1 2, Hyebin Lee 5 6, Han Suk Ryu
Pathobiology. 2025;92(1):40-51. Link
3657. The Prognostic Significance of Ki-67 Expression in Breast Cancers Developing Malignant Effusions
Ilias P Nikas 1, So Hyeon Yang 2, Sojung Lim 3, Hyebin Lee 4, Han Suk Ryu
Acta Cytol. 2025;69(4):352-360. Link
3656. Genome-scale knockout simulation and clustering analysis of drug-resistant breast cancer cells reveal drug sensitization targets
JinA Lim # 1, Hae Deok Jung # 1, Soo Young Park 2, Moonhyeon Jeon 1, Da Sol Kim 2, Ryeongeun Cho 1, Dohyun Han 3 4, Han Suk Ryu 2 5 6, Yoosik Kim 1 7 8 9, Hyun Uk Kim
Mol Cancer Ther. 2018 Dec;17(12):2507-2518 Link